KIAA1033 | KIAA1033 | 12q24.11 | 0.41 | 0.609 | 0
|
MED13L | mediator complex subunit 13-like | 12q24.22 | 0.376 | 0.592 | 0
|
POLK | polymerase (DNA directed) kappa | 5q13 | 0.361 | 0.591 | 0
|
PPP1R12A | protein phosphatase 1, regulatory subunit 12A | 12q15-q21 | 0.361 | 0.617 | 0
|
TTC37 | tetratricopeptide repeat domain 37 | 5q15 | 0.361 | 0.547 | 0
|
OSBPL8 | oxysterol binding protein-like 8 | 12q14 | 0.356 | 0.577 | 0
|
MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 2q21.1 | 0.354 | 0.511 | 0
|
IL6ST | interleukin 6 signal transducer | 5q11.2 | 0.354 | 0.562 | 0
|
KLHL20 | kelch-like family member 20 | 1q25.1 | 0.349 | 0.59 | 0
|
PJA2 | praja ring finger 2, E3 ubiquitin protein ligase | 5q22.1 | 0.344 | 0.557 | 0
|
OXLD1 | oxidoreductase-like domain containing 1 | 17q25.3 | 0.342 | -0.496 | 0
|
MRPL12 | mitochondrial ribosomal protein L12 | 17q25 | 0.34 | -0.496 | 0
|
MEF2A | myocyte enhancer factor 2A | 15q26 | 0.339 | 0.582 | 0
|
TTBK2 | tau tubulin kinase 2 | 15q15.2 | 0.337 | 0.578 | 0
|
CSGALNACT2 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | 10q11.21 | 0.337 | 0.519 | 0
|
LSM4 | LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated | 19p13.1 | 0.337 | -0.516 | 0
|
ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | 12q23 | 0.336 | 0.537 | 0
|
POLR2I | polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa | 19q13.12 | 0.334 | -0.439 | 0
|
REV3L | REV3-like, polymerase (DNA directed), zeta, catalytic subunit | 6q22 | 0.331 | 0.5 | 0
|
SNRPA | small nuclear ribonucleoprotein polypeptide A | 19q13.1 | 0.329 | -0.487 | 0
|
C1orf159 | chromosome 1 open reading frame 159 | 1p36.33 | 0.329 | -0.512 | 0
|
PLEKHJ1 | pleckstrin homology domain containing, family J member 1 | 19p13.3 | 0.328 | -0.53 | 0
|
DGUOK | deoxyguanosine kinase | 2p13 | 0.328 | -0.559 | 0
|
PCNXL4 | pecanex-like 4 (Drosophila) | 14q23.1 | 0.324 | 0.494 | 0
|
SERINC1 | serine incorporator 1 | 6q22.32 | 0.324 | 0.528 | 0
|
SS18L2 | synovial sarcoma translocation gene on chromosome 18-like 2 | 3p21 | 0.324 | -0.49 | 0
|
AP4E1 | adaptor-related protein complex 4, epsilon 1 subunit | 15q21.2 | 0.323 | 0.487 | 0
|
ZNF460 | zinc finger protein 460 | 19q13.4 | 0.323 | 0.411 | 0
|
KLHL28 | kelch-like family member 28 | 14q21.1 | 0.322 | 0.457 | 0
|
MRPL41 | mitochondrial ribosomal protein L41 | 9q34.3 | 0.322 | -0.459 | 0
|
PXK | PX domain containing serine/threonine kinase | 3p21.2 | 0.322 | 0.546 | 0
|
CDK17 | cyclin-dependent kinase 17 | 12q23.1 | 0.322 | 0.53 | 0
|
SSNA1 | Sjogren syndrome nuclear autoantigen 1 | 9q34.3 | 0.321 | -0.513 | 0
|
C19orf43 | chromosome 19 open reading frame 43 | 19p13.2 | 0.32 | -0.446 | 0
|
IL1RAP | interleukin 1 receptor accessory protein | 3q28 | 0.319 | 0.378 | 5.02e-16
|
ZDHHC17 | zinc finger, DHHC-type containing 17 | 12q21.2 | 0.317 | 0.455 | 0
|
SLC30A4 | solute carrier family 30 (zinc transporter), member 4 | 15q21.1 | 0.316 | 0.461 | 0
|
EEA1 | early endosome antigen 1 | 12q22 | 0.315 | 0.546 | 0
|
LSM7 | LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated | 19p13.3 | 0.315 | -0.435 | 0
|
UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 15q13 | 0.314 | 0.554 | 0
|
PCNX | pecanex homolog (Drosophila) | 14q24.2 | 0.314 | 0.537 | 0
|
MPND | MPN domain containing | 19p13.3 | 0.314 | -0.429 | 0
|
CCDC61 | coiled-coil domain containing 61 | 19q13.32 | 0.313 | -0.363 | 1.11e-14
|
SEL1L | sel-1 suppressor of lin-12-like (C. elegans) | 14q31 | 0.313 | 0.487 | 0
|
STRN3 | striatin, calmodulin binding protein 3 | 14q13-q21 | 0.313 | 0.533 | 0
|
HERC3 | HECT and RLD domain containing E3 ubiquitin protein ligase 3 | 4q21 | 0.313 | 0.519 | 0
|
ZNF593 | zinc finger protein 593 | 1p35.3 | 0.313 | -0.45 | 0
|
PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) | 19q13.1 | 0.311 | -0.516 | 0
|
DNAJB4 | DnaJ (Hsp40) homolog, subfamily B, member 4 | 1p31.1 | 0.309 | 0.511 | 0
|
LYPLA2 | lysophospholipase II | 1p36.11 | 0.309 | -0.47 | 0
|
CHD9 | chromodomain helicase DNA binding protein 9 | 16q12.2 | 0.309 | 0.574 | 0
|
ARRDC1 | arrestin domain containing 1 | 9q34.3 | 0.308 | -0.516 | 0
|
SSU72 | SSU72 homolog, RNA polymerase II CTD phosphatase | 1p36 | 0.308 | -0.455 | 0
|
PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 12q24.1 | 0.307 | 0.51 | 0
|
WDR44 | WD repeat domain 44 | Xq24 | 0.307 | 0.509 | 0
|
SLC25A46 | solute carrier family 25, member 46 | 5q22.1 | 0.304 | 0.5 | 0
|
SYNJ1 | synaptojanin 1 | 21q22.2 | 0.304 | 0.447 | 0
|
COX6B1 | cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) | 19q13.1 | 0.304 | -0.493 | 0
|
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 17q21 | 0.304 | 0.451 | 0
|
CLIP1 | CAP-GLY domain containing linker protein 1 | 12q24.3 | 0.303 | 0.479 | 0
|
C9orf116 | chromosome 9 open reading frame 116 | 9q34.3 | 0.303 | -0.521 | 0
|
QPCTL | glutaminyl-peptide cyclotransferase-like | 19q13.32 | 0.303 | -0.477 | 0
|
NR2C2AP | nuclear receptor 2C2-associated protein | 19p13.11 | 0.302 | -0.5 | 0
|
CCPG1 | cell cycle progression 1 | 15q21.1 | 0.302 | 0.434 | 0
|
OTUD4 | OTU deubiquitinase 4 | 4q31.21 | 0.302 | 0.451 | 0
|
HIAT1 | hippocampus abundant transcript 1 | 1p21.3 | 0.302 | 0.434 | 0
|
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 14q23.2 | 0.301 | 0.485 | 0
|
SLC25A10 | solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 | 17q25.3 | 0.301 | -0.501 | 0
|
MBNL1 | muscleblind-like splicing regulator 1 | 3q25 | 0.3 | 0.497 | 0
|
ING4 | inhibitor of growth family, member 4 | 12p13.32 | 0.3 | -0.339 | 8.13e-13
|
ATG2B | autophagy related 2B | 14q32.31 | 0.3 | 0.472 | 0
|
TRIM23 | tripartite motif containing 23 | 5q12.3 | 0.299 | 0.562 | 0
|
BUD31 | BUD31 homolog | 7q22.1 | 0.298 | -0.46 | 0
|
KLF10 | Kruppel-like factor 10 | 8q22.3 | 0.298 | 0.432 | 0
|
BOLA2 | bolA family member 2 | 16p11.2 | 0.297 | -0.476 | 0
|
SMIM4 | small integral membrane protein 4 | 3p21.1 | 0.297 | -0.398 | 0
|
TPRN | taperin | 9q34.3 | 0.296 | -0.555 | 0
|
C9orf16 | chromosome 9 open reading frame 16 | 9q34.1 | 0.296 | -0.525 | 0
|
POP7 | POP7 homolog, ribonuclease P/MRP subunit | 7q22 | 0.296 | -0.479 | 0
|
C19orf73 | chromosome 19 open reading frame 73 | 19q13.33 | 0.296 | -0.421 | 0
|
LAMP2 | lysosomal-associated membrane protein 2 | Xq24 | 0.294 | 0.388 | 0
|
MRPL38 | mitochondrial ribosomal protein L38 | 17q23-q25 | 0.294 | -0.532 | 0
|
UBALD2 | UBA-like domain containing 2 | 17q25.1 | 0.294 | -0.421 | 0
|
SGCB | sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) | 4q12 | 0.293 | 0.44 | 0
|
PPP4C | protein phosphatase 4, catalytic subunit | 16p11.2 | 0.293 | -0.475 | 0
|
PTGES2 | prostaglandin E synthase 2 | 9q34.12 | 0.293 | -0.472 | 0
|
TRAF4 | TNF receptor-associated factor 4 | 17q11-q21.3 | 0.292 | -0.444 | 0
|
HECTD2 | HECT domain containing E3 ubiquitin protein ligase 2 | 10q23.32 | 0.292 | 0.537 | 0
|
NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 5q31-q32 | 0.292 | 0.49 | 0
|
TMTC3 | transmembrane and tetratricopeptide repeat containing 3 | 12q21.32 | 0.291 | 0.432 | 0
|
NEK7 | NIMA-related kinase 7 | 1q31.3 | 0.288 | 0.512 | 0
|
NEK1 | NIMA-related kinase 1 | 4q32.3 | 0.287 | 0.543 | 0
|
SSH1 | slingshot protein phosphatase 1 | 12q24.12 | 0.287 | 0.452 | 0
|
HDHD3 | haloacid dehalogenase-like hydrolase domain containing 3 | 9q33.1 | 0.286 | -0.459 | 0
|
CEP85L | centrosomal protein 85kDa-like | 6q22.31 | 0.286 | 0.474 | 0
|
MRPS12 | mitochondrial ribosomal protein S12 | 19q13.1-q13.2 | 0.286 | -0.515 | 0
|
DNAJB14 | DnaJ (Hsp40) homolog, subfamily B, member 14 | 4q23 | 0.286 | 0.533 | 0
|
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | 3q13.31 | 0.286 | 0.374 | 1.14e-15
|
LPAR2 | lysophosphatidic acid receptor 2 | 19p12 | 0.285 | -0.473 | 0
|
UHRF1BP1L | UHRF1 binding protein 1-like | 12q23.1 | 0.284 | 0.455 | 0
|
MIER1 | mesoderm induction early response 1, transcriptional regulator | 1p31.2 | 0.283 | 0.46 | 0
|
PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha | 17q24.2 | 0.283 | 0.511 | 0
|
RPP38 | ribonuclease P/MRP 38kDa subunit | 10p13 | 0.283 | -0.386 | 3.73e-18
|
ARL13B | ADP-ribosylation factor-like 13B | 3q11 | 0.283 | 0.427 | 0
|
LRCH1 | leucine-rich repeats and calponin homology (CH) domain containing 1 | 13q14.11 | 0.282 | 0.462 | 0
|
ARRDC3 | arrestin domain containing 3 | 5q14.3 | 0.281 | 0.493 | 0
|
KIF9 | kinesin family member 9 | 3p21.31 | 0.281 | -0.394 | 0
|
MIEN1 | migration and invasion enhancer 1 | 17q12 | 0.281 | -0.434 | 0
|
TSEN54 | TSEN54 tRNA splicing endonuclease subunit | 17q25.1 | 0.28 | -0.479 | 0
|
OSBPL11 | oxysterol binding protein-like 11 | 3q21 | 0.28 | 0.412 | 0
|
MID2 | midline 2 | Xq22.1-q22.2 | 0.28 | 0.546 | 0
|
RALY | RALY heterogeneous nuclear ribonucleoprotein | 20q11.21-q11.23 | 0.278 | -0.478 | 0
|
EXOSC5 | exosome component 5 | 19q13.1 | 0.278 | -0.488 | 0
|
COQ4 | coenzyme Q4 | 9q34.2 | 0.278 | -0.476 | 0
|
TOR1AIP1 | torsin A interacting protein 1 | 1q24.2 | 0.278 | 0.539 | 0
|
HES6 | hes family bHLH transcription factor 6 | 2q37.3 | 0.277 | -0.458 | 0
|
SDF2 | stromal cell-derived factor 2 | 17q11.2 | 0.277 | -0.387 | 0
|
MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 6q15 | 0.277 | 0.429 | 0
|
FAM89B | family with sequence similarity 89, member B | 11q23 | 0.276 | -0.402 | 0
|
SETD7 | SET domain containing (lysine methyltransferase) 7 | 4q31.1 | 0.275 | 0.454 | 0
|
KIAA0825 | KIAA0825 | 5q15 | 0.275 | 0.428 | 0
|
USP51 | ubiquitin specific peptidase 51 | Xp11 | 0.274 | 0.432 | 0
|
TBRG4 | transforming growth factor beta regulator 4 | 7p13 | 0.273 | -0.412 | 0
|
VEZT | vezatin, adherens junctions transmembrane protein | 12q22 | 0.272 | 0.471 | 0
|
NHP2 | NHP2 ribonucleoprotein | 5q35.3 | 0.272 | -0.426 | 0
|
SLC16A7 | solute carrier family 16 (monocarboxylate transporter), member 7 | 12q14.1 | 0.271 | 0.448 | 0
|
PKD2 | polycystic kidney disease 2 (autosomal dominant) | 4q22.1 | 0.269 | 0.494 | 0
|
AP1M2 | adaptor-related protein complex 1, mu 2 subunit | 19p13.2 | 0.269 | -0.459 | 0
|
ACVR1 | activin A receptor, type I | 2q23-q24 | 0.268 | 0.391 | 0
|
CPEB3 | cytoplasmic polyadenylation element binding protein 3 | 10q23.33 | 0.268 | 0.473 | 0
|
UBE3B | ubiquitin protein ligase E3B | 12q24.12 | 0.267 | 0.391 | 0
|
BCL2L2 | BCL2-like 2 | 14q11.2-q12 | 0.267 | 0.387 | 0
|
FAM114A2 | family with sequence similarity 114, member A2 | 5q33.2 | 0.265 | 0.471 | 0
|
CBX8 | chromobox homolog 8 | 17q25.3 | 0.264 | -0.438 | 0
|
SLC2A8 | solute carrier family 2 (facilitated glucose transporter), member 8 | 9q33.3 | 0.264 | -0.361 | 1.79e-14
|
RNF145 | ring finger protein 145 | 5q33.3 | 0.264 | 0.482 | 0
|
CBLC | Cbl proto-oncogene C, E3 ubiquitin protein ligase | 19q13.2 | 0.263 | -0.443 | 0
|
FAM8A1 | family with sequence similarity 8, member A1 | 6p23 | 0.263 | 0.323 | 1.02e-11
|
TCF3 | transcription factor 3 | 19p13.3 | 0.263 | -0.33 | 3.5e-12
|
ZHX3 | zinc fingers and homeoboxes 3 | 20q12 | 0.263 | 0.47 | 0
|
UBR7 | ubiquitin protein ligase E3 component n-recognin 7 (putative) | 14q32.12 | 0.262 | 0.366 | 7.37e-15
|
LCMT1 | leucine carboxyl methyltransferase 1 | 16p12.1 | 0.262 | -0.411 | 0
|
STARD13 | StAR-related lipid transfer (START) domain containing 13 | 13q13.1 | 0.262 | 0.34 | 6.69e-13
|
NDUFA8 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa | 9q33.2 | 0.261 | -0.32 | 1.64e-11
|
PTRH2 | peptidyl-tRNA hydrolase 2 | 17q23.2 | 0.26 | -0.409 | 0
|
TMEM125 | transmembrane protein 125 | 1p34.2 | 0.259 | -0.426 | 0
|
DDR2 | discoidin domain receptor tyrosine kinase 2 | 1q12-q23 | 0.259 | 0.39 | 0
|
TRUB2 | TruB pseudouridine (psi) synthase family member 2 | 9q34.11 | 0.259 | -0.503 | 0
|
AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | 9q34.3 | 0.258 | -0.45 | 0
|
KLHL42 | kelch-like family member 42 | 12p11.22 | 0.258 | 0.401 | 0
|
FAM136A | family with sequence similarity 136, member A | 2p14 | 0.257 | -0.431 | 0
|
WWC2 | WW and C2 domain containing 2 | 4q35.1 | 0.257 | 0.447 | 0
|
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | 1q32.1 | 0.257 | 0.432 | 0
|
C17orf96 | chromosome 17 open reading frame 96 | 17q12 | 0.256 | -0.394 | 0
|
CCSER2 | coiled-coil serine-rich protein 2 | 10q23.1 | 0.255 | 0.526 | 0
|
AKR1A1 | aldo-keto reductase family 1, member A1 (aldehyde reductase) | 1p33-p32 | 0.254 | -0.479 | 0
|
SLC2A13 | solute carrier family 2 (facilitated glucose transporter), member 13 | 12q12 | 0.253 | 0.479 | 0
|
GTF3C5 | general transcription factor IIIC, polypeptide 5, 63kDa | 9q34.13 | 0.252 | -0.413 | 0
|
PDP1 | pyruvate dehyrogenase phosphatase catalytic subunit 1 | 8q22.1 | 0.252 | 0.314 | 3.88e-11
|
PERP | PERP, TP53 apoptosis effector | 6q24 | 0.252 | 0.066 | 0.172
|
PRKAB2 | protein kinase, AMP-activated, beta 2 non-catalytic subunit | 1q21.2 | 0.252 | 0.353 | 7.04e-14
|
VGF | VGF nerve growth factor inducible | 7q22 | 0.251 | -0.455 | 0
|
YAP1 | Yes-associated protein 1 | 11q13 | 0.251 | 0.464 | 0
|
SNAPC4 | small nuclear RNA activating complex, polypeptide 4, 190kDa | 9q34.3 | 0.251 | -0.458 | 0
|
USP15 | ubiquitin specific peptidase 15 | 12q14 | 0.249 | 0.481 | 0
|
LYST | lysosomal trafficking regulator | 1q42.1-q42.2 | 0.249 | 0.436 | 0
|
STARD4 | StAR-related lipid transfer (START) domain containing 4 | 5q22 | 0.248 | 0.392 | 0
|
C9orf114 | chromosome 9 open reading frame 114 | 9q34.11 | 0.248 | -0.422 | 0
|
FA2H | fatty acid 2-hydroxylase | 16q23 | 0.247 | -0.3 | 3.28e-10
|
CLIP4 | CAP-GLY domain containing linker protein family, member 4 | 2p23 | 0.246 | 0.438 | 0
|
CTXN1 | cortexin 1 | 19p13.2 | 0.245 | -0.351 | 1.18e-13
|
DLGAP1-AS1 | DLGAP1 antisense RNA 1 | 18p11.31 | 0.245 | -0.371 | 2.39e-15
|
SBDS | Shwachman-Bodian-Diamond syndrome | 7q11.22 | 0.244 | 0.346 | 2.61e-13
|
SETBP1 | SET binding protein 1 | 18q21.1 | 0.244 | 0.422 | 0
|
GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 12q24.1 | 0.244 | 0.432 | 0
|
ZFHX4 | zinc finger homeobox 4 | 8q21.11 | 0.243 | 0.397 | 0
|
TMEM102 | transmembrane protein 102 | 17p13.1 | 0.241 | -0.388 | 0
|
MRPS33 | mitochondrial ribosomal protein S33 | 7q34 | 0.241 | -0.349 | 1.45e-13
|
SDCCAG3 | serologically defined colon cancer antigen 3 | 9q34.3 | 0.241 | -0.398 | 0
|
RIC8B | RIC8 guanine nucleotide exchange factor B | 12q23.3 | 0.239 | 0.402 | 0
|
SLC19A1 | solute carrier family 19 (folate transporter), member 1 | 21q22.3 | 0.239 | -0.42 | 0
|
KITLG | KIT ligand | 12q22 | 0.238 | 0.406 | 0
|
AGMAT | agmatine ureohydrolase (agmatinase) | 1p36.13 | 0.238 | -0.37 | 2.8e-15
|
FCHO1 | FCH domain only 1 | 19p13.12 | 0.237 | -0.376 | 7.02e-16
|
DYNC2H1 | dynein, cytoplasmic 2, heavy chain 1 | 11q21-q22.1 | 0.236 | 0.462 | 0
|
C20orf195 | chromosome 20 open reading frame 195 | 20q13.33 | 0.235 | -0.357 | 3.53e-14
|
TMX4 | thioredoxin-related transmembrane protein 4 | 20p12 | 0.235 | 0.412 | 0
|
SLC25A33 | solute carrier family 25 (pyrimidine nucleotide carrier), member 33 | 1p36.22 | 0.232 | -0.259 | 6.26e-08
|
SEC22B | SEC22 homolog B, vesicle trafficking protein (gene/pseudogene) | 1q21.1 | 0.232 | 0.067 | 0.17
|
MEF2D | myocyte enhancer factor 2D | 1q12-q23 | 0.23 | 0.352 | 9.1e-14
|
ASB13 | ankyrin repeat and SOCS box containing 13 | 10p15.1 | 0.23 | -0.33 | 3.76e-12
|
AZI2 | 5-azacytidine induced 2 | 3p23 | 0.228 | 0.358 | 2.92e-14
|
NDOR1 | NADPH dependent diflavin oxidoreductase 1 | 9q34.3 | 0.228 | -0.434 | 0
|
SLC25A30 | solute carrier family 25, member 30 | 13q14 | 0.227 | 0.388 | 0
|
LYRM1 | LYR motif containing 1 | 16p12.2 | 0.226 | -0.239 | 6.42e-07
|
GPRASP2 | G protein-coupled receptor associated sorting protein 2 | Xq22.1 | 0.226 | 0.39 | 0
|
KIAA0513 | KIAA0513 | 16q24.1 | 0.226 | 0.297 | 4.41e-10
|
KCNS3 | potassium voltage-gated channel, modifier subfamily S, member 3 | 2p24 | 0.225 | -0.212 | 1.01e-05
|
ATP5J | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 | 21q21.1 | 0.225 | -0.175 | 0.00029
|
RPL7A | ribosomal protein L7a | 9q34 | 0.225 | -0.304 | 1.85e-10
|
PHTF2 | putative homeodomain transcription factor 2 | 7q11.23-q21.11 | 0.224 | 0.341 | 5.8e-13
|
PDE5A | phosphodiesterase 5A, cGMP-specific | 4q27 | 0.224 | 0.32 | 1.55e-11
|
PPP3CA | protein phosphatase 3, catalytic subunit, alpha isozyme | 4q24 | 0.222 | 0.31 | 7.28e-11
|
ANKRD13B | ankyrin repeat domain 13B | 17q11.2 | 0.22 | -0.296 | 5.07e-10
|
CDKN2AIPNL | CDKN2A interacting protein N-terminal like | 5q31.1 | 0.219 | -0.298 | 4.08e-10
|
APOBEC3F | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F | 22q13.1-q13.2 | 0.216 | -0.333 | 2.11e-12
|
TMPRSS13 | transmembrane protease, serine 13 | 11q23 | 0.215 | 0.083 | 0.0878
|
TRAIP | TRAF interacting protein | 3p21.31 | 0.214 | -0.364 | 9.8e-15
|
COPZ1 | coatomer protein complex, subunit zeta 1 | 12q13.2-q13.3 | 0.214 | -0.291 | 9.98e-10
|
DDX28 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 | 16q22.1-q22.3 | 0.214 | -0.377 | 5.06e-16
|
PPP1R26 | protein phosphatase 1, regulatory subunit 26 | 9q34.3 | 0.212 | -0.352 | 9.55e-14
|
SLC27A4 | solute carrier family 27 (fatty acid transporter), member 4 | 9q34.13 | 0.212 | -0.396 | 0
|
VAX2 | ventral anterior homeobox 2 | 2p13.3 | 0.212 | -0.116 | 0.0165
|
PTGR1 | prostaglandin reductase 1 | 9q32 | 0.211 | -0.09 | 0.0641
|
C6orf47 | chromosome 6 open reading frame 47 | 6p21.3 | 0.211 | -0.311 | 6.27e-11
|
PCGF6 | polycomb group ring finger 6 | 10q24.33 | 0.21 | 0.21 | 1.31e-05
|
VAMP4 | vesicle-associated membrane protein 4 | 1q24-q25 | 0.209 | 0.345 | 2.8e-13
|
PCGF5 | polycomb group ring finger 5 | 10q23.33 | 0.209 | 0.359 | 2.78e-14
|
TUBG1 | tubulin, gamma 1 | 17q21.31 | 0.208 | -0.215 | 7.82e-06
|
TMEM11 | transmembrane protein 11 | 17p11.1 | 0.208 | -0.353 | 7.46e-14
|
KCTD10 | potassium channel tetramerization domain containing 10 | 12q24.12 | 0.208 | 0.33 | 3.79e-12
|
GPHN | gephyrin | 14q23.3 | 0.207 | 0.325 | 7.62e-12
|
HCG4 | HLA complex group 4 (non-protein coding) | 6p22.1 | 0.207 | 0.247 | 2.61e-07
|
MR1 | major histocompatibility complex, class I-related | 1q25.3 | 0.206 | 0.243 | 3.88e-07
|
ANKLE1 | ankyrin repeat and LEM domain containing 1 | 19p13.11 | 0.205 | -0.248 | 2.25e-07
|
BCL2L14 | BCL2-like 14 (apoptosis facilitator) | 12p13-p12 | 0.205 | -0.197 | 4.31e-05
|
ARHGAP39 | Rho GTPase activating protein 39 | 8q24.3 | 0.204 | -0.327 | 5.67e-12
|
SLC15A4 | solute carrier family 15 (oligopeptide transporter), member 4 | 12q24.32 | 0.204 | 0.263 | 3.8e-08
|
GREB1L | growth regulation by estrogen in breast cancer-like | 18q11.2 | 0.203 | 0.014 | 0.77
|
RMI2 | RecQ mediated genome instability 2 | 16p13.13 | 0.199 | -0.342 | 4.92e-13
|
AGBL5 | ATP/GTP binding protein-like 5 | 2p23.3 | 0.193 | -0.136 | 0.00479
|
TSLP | thymic stromal lymphopoietin | 5q22.1 | 0.192 | 0.321 | 1.32e-11
|
COX6B2 | cytochrome c oxidase subunit VIb polypeptide 2 (testis) | 19q13.42 | 0.19 | -0.085 | 0.0811
|
TRPC1 | transient receptor potential cation channel, subfamily C, member 1 | 3q23 | 0.18 | 0.296 | 5.59e-10
|
METTL21B | methyltransferase like 21B | 12q14.1 | 0.174 | 0.217 | 6.53e-06
|
RSL1D1 | ribosomal L1 domain containing 1 | 16p13.13 | 0.171 | -0.21 | 1.3e-05
|